Literature DB >> 11172479

Oral nicotine administration decreases tumor necrosis factor-alpha expression in fat tissues in obese rats.

R H Liu1, T Kurose, S Matsukura.   

Abstract

To investigate the effect of oral nicotine administration on insulin resistance and insulin secretion in an animal model of obesity, Zucker fatty rats were administered nicotine tartrate dihydrate orally through tap water (4.6 mg/kg/d, N group). Plasma nicotine concentrations in N group were 33.67 +/- 10.49 ng/mL. The control (C) group consisted of pair-fed control rats. After 8 weeks of nicotine administration, both groups of rats were administered glucose (2 g/kg) orally in an anesthetized state, and blood was collected for glucose and plasma insulin measurements. The pancreases were isolated and perfused in vitro under pentobarbital anesthesia 1 week after glucose administration. The fat tissues were excised. The levels of tumor necrosis factor (TNF)-alpha protein were assessed using enzyme-linked immunosorbent assay (ELISA) or Western blot analysis. Serum leptin levels were measured using radioimmunoassay (RIA). Blood glucose levels in N group were significantly lower than in C group before and 120 minutes after glucose administration. The insulin secretion from the isolated perfused pancreases of N group appeared to be decreased compared with C group, but there was no significant difference. Histologic examination showed that the mean size of the pancreatic islets in N group was significantly smaller than in C group. The composition ratios of alpha and beta cell mass of the pancreatic islets and fibroelastic tissues were not altered by nicotine administration. Portal TNF-alpha levels were comparable to peripheral levels in both groups. There were no significant differences in peripheral serum levels of TNF-alpha, free fatty acids (FFA), or leptin levels between N and C group. The TNF-alpha levels in visceral fat tissues in N group were significantly lower than those in C group. These results suggest that oral nicotine administration reduces insulin resistance in obese diabetic rats by decreasing production of TNF-alpha in the visceral fat tissues. Decreased islet size may be a secondary phenomenon induced by ameliorated insulin resistance, because the cellularity and fibroelastic tissues were not affected by the nicotine.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11172479     DOI: 10.1053/meta.2001.19436

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  9 in total

1.  Cholinergic activation suppresses palmitate-induced macrophage activation and improves acylation stimulating protein resistance in co-cultured adipocytes.

Authors:  Jing Wu; Zhou-Yang Jiao; Rui-Zhen Li; Hui-Ling Lu; Hao-Hao Zhang; Katherine Cianflone
Journal:  Exp Biol Med (Maywood)       Date:  2017-03-20

2.  Activation of the cholinergic antiinflammatory pathway ameliorates obesity-induced inflammation and insulin resistance.

Authors:  XianFeng Wang; ZhengGang Yang; Bingzhong Xue; Hang Shi
Journal:  Endocrinology       Date:  2011-01-14       Impact factor: 4.736

3.  Gut bacteria alleviate smoking-related NASH by degrading gut nicotine.

Authors:  Bo Chen; Lulu Sun; Guangyi Zeng; Zhe Shen; Kai Wang; Limin Yin; Feng Xu; Pengcheng Wang; Yong Ding; Qixing Nie; Qing Wu; Zhiwei Zhang; Jialin Xia; Jun Lin; Yuhong Luo; Jie Cai; Kristopher W Krausz; Ruimao Zheng; Yanxue Xue; Ming-Hua Zheng; Yang Li; Chaohui Yu; Frank J Gonzalez; Changtao Jiang
Journal:  Nature       Date:  2022-10-19       Impact factor: 69.504

Review 4.  Therapeutic potential of α7 nicotinic acetylcholine receptor agonists to combat obesity, diabetes, and inflammation.

Authors:  Han Xie; Natesh Yepuri; Qinghe Meng; Ravi Dhawan; Colin A Leech; Oleg G Chepurny; George G Holz; Robert N Cooney
Journal:  Rev Endocr Metab Disord       Date:  2020-08-26       Impact factor: 6.514

5.  Glutamic acid decarboxylase antibodies are indicators of the course, but not of the onset, of diabetes in middle-aged adults: the Atherosclerosis Risk in Communities Study.

Authors:  A Vigo; B B Duncan; M I Schmidt; D Couper; G Heiss; J S Pankow; C M Ballantyne
Journal:  Braz J Med Biol Res       Date:  2007-07       Impact factor: 2.590

6.  Smoking, smoking cessation, and risk for type 2 diabetes mellitus: a cohort study.

Authors:  Hsin-Chieh Yeh; Bruce B Duncan; Maria Inês Schmidt; Nae-Yuh Wang; Frederick L Brancati
Journal:  Ann Intern Med       Date:  2010-01-05       Impact factor: 25.391

7.  Nicotinic acetylcholine receptor signaling regulates inositol-requiring enzyme 1α activation to protect β-cells against terminal unfolded protein response under irremediable endoplasmic reticulum stress.

Authors:  Tatsuya Ishibashi; Shuhei Morita; Shohei Kishimoto; Shinsuke Uraki; Ken Takeshima; Yasushi Furukawa; Hidefumi Inaba; Hiroyuki Ariyasu; Hiroshi Iwakura; Hiroto Furuta; Masahiro Nishi; Feroz R Papa; Takashi Akamizu
Journal:  J Diabetes Investig       Date:  2020-02-17       Impact factor: 4.232

8.  The Constitutive Lack of α7 Nicotinic Receptor Leads to Metabolic Disorders in Mouse.

Authors:  Blandine Gausserès; Junjun Liu; Ewout Foppen; Cécile Tourrel-Cuzin; Ana Rodriguez Sanchez-Archidona; Etienne Delangre; Céline Cruciani-Guglielmacci; Stéphanie Pons; Uwe Maskos; Bernard Thorens; Christophe Magnan; Jamileh Movassat; Kamel Maouche
Journal:  Biomolecules       Date:  2020-07-16

Review 9.  Obese Smokers as a Potential Subpopulation of Risk in Tobacco Reduction Policy.

Authors:  Laura E Rupprecht; Eric C Donny; Alan F Sved
Journal:  Yale J Biol Med       Date:  2015-09-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.